Abstract
There are some indications that biased μ-opioid ligands may diversely affect μ-opioid receptor (MOR) properties. Here, we used confocal fluorescence recovery after photobleaching (FRAP) to study the regulation by different MOR agonists of receptor movement within the plasma membrane of HEK293 cells stably expressing a functional yellow fluorescent protein (YFP)-tagged μ-opioid receptor (MOR-YFP). We found that the lateral mobility of MOR-YFP was increased by (D-Ala2,N-MePhe4,Gly5-ol)-enkephalin (DAMGO) and to a lesser extent also by morphine but decreased by endomorphin-2. Interestingly, cholesterol depletion strongly enhanced the ability of morphine to elevate receptor mobility but significantly reduced or even eliminated the effect of DAMGO and endomorphin-2, respectively. Moreover, the ability of DAMGO and endomorphin-2 to influence MOR-YFP movement was diminished by pertussis toxin treatment. The results obtained by agonist-stimulated [35S]GTPγS binding assays indicated that DAMGO exhibited higher efficacy than morphine and endomorphin-2 did and that the efficacy of DAMGO, contrary to the latter agonists, was enhanced by cholesterol depletion. Overall, our study provides clear evidence that biased MOR agonists diversely affect receptor mobility in plasma membranes as well as MOR/G protein coupling and that the regulatory effect of different ligands depends on the membrane cholesterol content. These findings help to delineate the fundamental properties of MOR regarding their interaction with biased MOR ligands and cognate G proteins.
Similar content being viewed by others
References
Allen JA, Halverson-Tamboli RA, Rasenick MM (2007) Lipid raft microdomains and neurotransmitter signalling. Nature Rev Neurosci 8:128–140
Almarza G, Sanchez F, Barrantes FJ (2014) Transient cholesterol effects on nicotinic acetylcholine receptor cell-surface mobility. PLoS One 9:e100346
Baier CJ, Gallegos CE, Levi V, Barrantes FJ (2010) Cholesterol modulation of nicotinic acetylcholine receptor surface mobility. Eur Biophys J 39:213–227
Baker A, Sauliere A, Dumas F, Millot C, Mazeres S, Lopez A, Salome L (2007) Functional membrane diffusion of G-protein coupled receptors. Eur Biophys J 36:849–860
Brejchova J, Sykora J, Ostasov P, Merta L, Roubalova L, Janacek J, Hof M, Svoboda P (2015) TRH-receptor mobility and function in intact and cholesterol-depleted plasma membrane of HEK293 cells stably expressing TRH-R-eGFP. Biochim Biophys Acta 1848:781–796
Briddon SJ, Hill SJ (2007) Pharmacology under the microscope: the use of fluorescence correlation spectroscopy to determine the properties of ligand-receptor complexes. Trends Pharmacol Sci 28:637–645
Carayon K, Mouledous L, Combedazou A, Mazeres S, Haanappel E, Salome L, Mollereau C (2014) Heterologous regulation of mu-opioid (MOP) receptor mobility in the membrane of SH-SY5Y cells. J Biol Chem 289:28697–28706
Chen SR, Pan HL (2006) Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia. J Neurophysiol 95:3086–3096
Cox BM, Christie MJ, Devi L, Toll L, Traynor JR (2015) Challenges for opioid receptor nomenclature: IUPHAR review 9. Br J Pharmacol 172:317–323
Desai AJ, Harikumar KG, Miller LJ (2014) A type 1 cholecystokinin receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment. J Biol Chem 289:18314–18326
Drastichova Z, Bourova L, Hejnova L, Jedelsky P, Svoboda P, Novotny J (2010) Protein alterations induced by long-term agonist treatment of HEK293 cells expressing thyrotropin-releasing hormone receptor and G(11)alpha protein. J Cell Biochem 109:255–264
Emmerson PJ, Clark MJ, Medzihradsky F, Remmers AE (1999) Membrane microviscosity modulates mu-opioid receptor conformational transitions and agonist efficacy. J Neurochem 73:289–300
Fernandes CC, Berg DK, Gomez-Varela D (2010) Lateral mobility of nicotinic acetylcholine receptors on neurons is determined by receptor composition, local domain, and cell type. J Neurosci 30:8841–8851
Gaibelet G, Millot C, Lebrun C, Ravault S, Sauliere A, Andre A, Lagane B, Lopez A (2008) Cholesterol content drives distinct pharmacological behaviours of mu-opioid receptor in different microdomains of the CHO plasma membrane. Mol Membrane Biol 25:423–435
Gimpl G, Wiegand V, Burger K, Fahrenholz F (2002) Cholesterol and steroid hormones: modulators of oxytocin receptor function. Prog Brain Res 139:43–55
Huang P, Xu W, Yoon S-I, Chen C, Chong PL-G, Unterwald EM, Liu-Chen L-Y (2007) Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells. Brain Res 1184:46–56
Jaskolski F, Henley JM (2009) Synaptic receptor trafficking: the lateral point of view. Neuroscience 158:19–24
Kahsai AW, Xiao K, Rajagopal S, Ahn S, Shukla AK, Sun J, Oas TG, Lefkowitz RJ (2011) Multiple ligand-specific conformations of the beta(2)-adrenergic receptor. Nature Chem Biol 7:692–700
Kilander MBC, Dahlstrom J, Schulte G (2014) Assessment of frizzled 6 membrane mobility by FRAP supports G protein coupling and reveals WNT-frizzled selectivity. Cell Signal 26:1943–1949
Kilpatrick LE, Hill SJ (2016) The use of fluorescence correlation spectroscopy to characterize the molecular mobility of fluorescently labelled G protein-coupled receptors. Biochem Soc Trans 44:624–629
Kilpatrick LE, Briddon SJ, Holliday ND (2012) Fluorescence correlation spectroscopy, combined with bimolecular fluorescence complementation, reveals the effects of beta-arrestin complexes and endocytic targeting on the membrane mobility of neuropeptide Y receptors. Biochim Biophys Acta 1823:1068–1081
Knott C, Maguire JJ, Moratalla R, Bowery NG (1993) Regional effects of pertussis toxin in vivo and in vitro on GABA-B receptor-binding in rat brain. Neuroscience 52:73–81
Ladepeche L, Dupuis JP, Groc L (2014) Surface trafficking of NMDA receptors: gathering from a partner to another. Semin Cell Dev Biol 27:3–13
Levitt ES, Clark MJ, Jenkins PM, Martens JR, Traynor JR (2009) Differential effect of membrane cholesterol removal on mu- and delta-opioid receptors a parallel comparison of acute and chronic signaling to adenylyl cyclase. J Biol Chem 284:22108–22122
Ma X, Wang Q, Jiang Y, Xiao Z, Fang X, Chen Y-G (2007) Lateral diffusion of TGF-beta type I receptor studied by single-molecule imaging. Biochem Biophys Res Commun 356:67–71
McPherson J, Rivero G, Baptist M, Llorente J, Al-Sabah S, Krasel C, Dewey WL, Bailey CP, Rosethorne EM, Charlton SJ, Henderson G, Kelly E (2010) Mu-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization. Mol Pharmacol 78:756–766
Molinari P, Vezzi V, Sbraccia M, Gro C, Riitano D, Ambrosio C, Casella I, Costa T (2010) Morphine-like opiates selectively antagonize receptor-arrestin interactions. J Biol Chem 285:12522–12535
Oates J, Faust B, Attrill H, Harding P, Orwick M, Watts A (2012) The role of cholesterol on the activity and stability of neurotensin receptor 1. Biochim Biophys Acta 1818:2228–2233
Orr G, Hu DH, Ozcelik S, Opresko LK, Wiley HS, Colson SD (2005) Cholesterol dictates the freedom of EGF receptors and HER2 in the plane of the membrane. Biophys J 89:1362–1373
Ostasov P, Bourova L, Hejnova L, Novotny J, Svoboda P (2007) Disruption of the plasma membrane integrity by cholesterol depletion impairs effectiveness of TRH receptor-mediated signal transduction via G(q)/G(11)alpha proteinse. J Recept Signal Transduction 27:335–352
Owen DM, Williamson D, Rentero C, Gaus K (2009) Quantitative microscopy: protein dynamics and membrane organisation. Traffic 10:962–971
Paila YD, Chattopadhyay A (2010) Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell Biochem 51:439–466
Paila YD, Jindal E, Goswami SK, Chattopadhyay A (2011) Cholesterol depletion enhances adrenergic signaling in cardiac myocytes. Biochim Biophys Acta 1808:461–465
Pasternak GW, Pan Y-X (2013) Mu opioids and their receptors: evolution of a concept. Pharmacol Rev 65:1257–1317
Pramanik A, Olsson M, Langel U, Bartfai T, Rigler R (2001) Fluorescence correlation spectroscopy detects galanin receptor diversity on insulinoma cells. Biochemistry 40:10839–10845
Pucadyil TJ, Chattopadhyay A (2007) Cholesterol depletion induces dynamic confinement of the G-protein coupled serotonin(1A) receptor in the plasma membrane of living cells. Biochim Biophys Acta 1768:655–668
Pucadyil TJ, Kalipatnapu S, Hirikumar KG, Rangaraj N, Karnik SS, Chattopadhyay A (2004) G-protein-dependant cell surface dynamics of the human serotonin(1A) receptor tagged to yellow fluorescent protein. Biochemistry 43:15852–15862
Qiu Y, Wang Y, Law P-Y, Chen H-Z, Loh HH (2011) Cholesterol regulates mu-opioid receptor-induced beta-arrestin 2 translocation to membrane lipid rafts. Mol Pharmacol 80:210–218
Rapsomaniki MA, Kotsantis P, Symeonidou I-E, Giakoumakis N-N, Taraviras S, Lygerou Z (2012) easyFRAP: an interactive, easy-to-use tool for qualitative and quantitative analysis of FRAP data. Bioinformatics 28:1800–1801
Reiter E, Ahn S, Shukla AK, Lefkowitz RJ (2012) Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol 52:179–197
Rivero G, Llorente J, McPherson J, Cooke A, Mundell SJ, McArdle CA, Rosethorne EM, Charlton SJ, Krasel C, Bailey CP, Henderson G, Kelly E (2012) Endomorphin-2: a biased agonist at the mu-opioid receptor. Mol Pharmacol 82:178–188
Sauliere A, Gaibelet G, Millot C, Mazeres S, Lopez A, Salome L (2006) Diffusion of the mu opioid receptor at the surface of human neuroblastoma SH-SY5Y cells is restricted to permeable domains. FEBS Lett 580:5227–5231
Sauliere-Nzeh AN, Millot C, Corbani M, Mazeres S, Lopez A, Salome L (2010) Agonist-selective dynamic compartmentalization of human mu opioid receptor as revealed by resolutive FRAP analysis. J Biol Chem 285:14514–14520
Saxena R, Chattopadhyay A (2011) Membrane organization and dynamics of the serotonin(1A) receptor in live cells. J Neurochem 116:726–733
Snaar-Jagalska BE, Cambi A, Schmidt T, de Keijzer S (2013) Single-molecule imaging technique to study the dynamic regulation of GPCR function at the plasma membrane. Methods Enzymol 521:47–67
Soumpasis DM (1983) Theoretical analysis of fluorescence photobleaching recovery experiments. Biophys J 41:95–97
Thompson GL, Lane JR, Coudrat T, Sexton PM, Christopoulos A, Canals M (2015) Biased agonism of endogenous opioid peptides at the mu-opioid receptor. Mol Pharmacol 88:335–346
Veya L, Piguet J, Vogel H (2015) Single molecule imaging deciphers the relation between mobility and signaling of a prototypical G protein-coupled receptor in living cells. J Biol Chem 290:27723–27735
Vigano D, Rubino T, Di Chiara G, Ascari I, Massi P, Parolaro D (2003) Mu-opioid receptor signaling in morphine sensitization. Neuroscience 117:921–929
Vukojevic V, Ming Y, D’Addario C, Hansen M, Langel U, Schulz R, Johansson B, Rigler R, Terenius L (2008) Mu-opioid receptor activation in live cells. FASEB J 22:3537–3548
Walker JM (1994) The bicinchoninic acid (BCA) assay for protein quantitation. Methods Mol Biol 32:5–8
Acknowledgments
This work was supported by the Charles University Grant Agency (798213) and cofinanced by the European Regional Development Fund and the state budget of the Czech Republic (CZ.1.05/4.1.00/16.0347).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Melkes, B., Hejnova, L. & Novotny, J. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins. Naunyn-Schmiedeberg's Arch Pharmacol 389, 1289–1300 (2016). https://doi.org/10.1007/s00210-016-1293-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-016-1293-8